Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitroI V Bijnsdorp, Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids|December 3, 2011
Deoxyribose protects against rapamycin-induced cytotoxicity in colorectal cancer cells in vitroI V Bijnsdorp, G J Peters
Nucleic Acids Symposium Series (2004)|September 9, 2008
Thymidine phoshorylase as a target for antiangiogenesis treatmentG J Peters, I V Bijnsdorp, M Fukushima
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Trifluorothymidine induces cell death independently of p53I V Bijnsdorp, F A Kruyt, M Fukushima, et al.
Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Increased migration by stimulation of thymidine phosphorylase in endothelial cells of different originI V Bijnsdorp, K Vrijland, L Vroling, et al.
Cancer Science|October 30, 2008
Synergistic interaction between trifluorothymidine and docetaxel is sequence dependentI V Bijnsdorp, F A Kruyt, S Gokoel, et al.
British Journal of Cancer|November 22, 2012
A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasisI V Bijnsdorp, L Rozendaal, R J A van Moorselaar, et al.
Oncology Reports|June 6, 2007
Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibitionI V Bijnsdorp, E M Comijn, J M Padron, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behaviorI V Bijnsdorp, M de Bruin, A C Laan, et al.
Current Medicinal Chemistry|November 12, 2009
Innovations and opportunities to improve conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancerA D Adema, I V Bijnsdorp, M L Sandvold, et al.
Pageof 2